scispace - formally typeset
M

Melissa M. Hudson

Researcher at University of Tennessee Health Science Center

Publications -  77
Citations -  6343

Melissa M. Hudson is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Cancer & Cohort study. The author has an hindex of 37, co-authored 77 publications receiving 5588 citations. Previous affiliations of Melissa M. Hudson include St. Jude Children's Research Hospital & Rice University.

Papers
More filters
Journal ArticleDOI

Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer

TL;DR: Among adult survivors of childhood cancer, the prevalence of adverse health outcomes was high, and a systematic risk-based medical assessment identified a substantial number of previously undiagnosed problems that are more prevalent in an older population.
Journal ArticleDOI

Health Status of Adult Long-term Survivors of Childhood Cancer A Report From the Childhood Cancer Survivor Study

TL;DR: Clinicians caring for adult survivors of childhood cancer should be aware of the substantial risk for adverse health status, especially among females, those withLow educational attainment, and those with low household incomes.
Journal ArticleDOI

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

TL;DR: Children with acute lymphoblastic leukemia who did not receive radiation therapy and who have attained 10 or more years of event-free survival can expect a normal long-term survival, and Irradiation is associated with the development of second neoplasms, a slight excess in mortality, and an increased unemployment rate.
Journal ArticleDOI

Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia

TL;DR: The results suggest that lifelong follow-up of acute lymphoblastic leukemia survivors is needed to ascertain the full impact of treatment and other leukemia-related factors on secondary neoplasm development and the increase in incidence of more aggressive malignant neoplasms is significantly higher than expected in the general population.